Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody

Intravenous immunoglobulin (IVIg) has been used to treat inflammatory demyelinating diseases such as chronic inflammatory demyelinating polyneuropathy, Guillain–Barré syndrome, and multifocal motor neuropathy. Despite studies demonstrating the clinical effectiveness of IVIg, the mechanisms underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales: SETOGUCHI, Yuki, HAYASHI, Akiko, KAWADA, Ayami, IBUSUKI, Ayako, YANAOKA, Daigo, SAITO, Ryota, ISHIBASHI, Tomoko, TAKIMOTO, Hiroaki, YAMAGUCHI, Yoshihide, OHTAKI, Hirokazu, BABA, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Academy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020422/
https://www.ncbi.nlm.nih.gov/pubmed/36775342
http://dx.doi.org/10.2183/pjab.99.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020422/
https://www.ncbi.nlm.nih.gov/pubmed/36775342
http://dx.doi.org/10.2183/pjab.99.004

Ejemplares similares